Phase 3 Study of MRTX849 in Lung Cancer

A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

Disease Types: Lung

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

For more information:

https://clinicaltrials.gov/ct2/show/NCT04685135?term=A+Randomized+Phase+3+Study+of+MRTX849+versus+Docetaxel+in+Patients+with+Previously+Treated+Non-Small+Cell+Lung+Cancer+with+KRAS+G12C+Mutation&draw=2&rank=1